SoftBank is set to exit smart scheduling software developer X.ai as its Vision Fund 2 invests in artificial intelligence technology unicorn AInnovation.

Munich Re and Centene-backed digital health software provider Babylon Health is set to get a public listing through the deal.

Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

IP Group sold a $5m stake to incoming shareholder Celltrion as part of a series A round for Iksuda, a spinout of Bath originally called Glythera.

The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.

IP Group sold a $5m stake to biopharmaceutical company Celltrion as part of a series A round for oncology therapy developer Iksuda.

Nina Gerson, Jamie Rosen and Jeremy Zhu have all stepped up after conducting a number of deals on behalf of Alphabet's growth equity subsidiary.

Citi has now invested in Greenwood, MoCaFi, Moving Analytics, OhmConnect and Sweeten through its $200m Impact Fund.

Alexandria Venture Investments has contributed to the debut round for newly launched protein therapeutics startup Stablix Therapeutics.

WuXi AppTec co-led a round for Junshi and Yitai-backed Stemirna, which is putting the funding into development of an mRNA vaccine for covid-19.